A Brief Outline of COVID 19 Specific Therapy in Hospitalised Patients In India

ABSTRACT

COVID 19 pandemic has a significant impact on global public health and economies. Scientists and researchers all over the world are endeavouring in search of specific drug against COVID19 virus. For a novel emerging virus, specific antiviral drug takes time before its approval for clinical use as RCTs are expensive and time consuming. In Indian perspective, many drugs which are currently under clinical trial are unavailable. Reviewing available published and unpublished papers, we intend to throw light on the drugs that can be used in the interim in India till further evidence come. Pending sufficient evidence remdesivir, favipirvair,tocilizumab,lopinavir-ritonavir with or without ribavirin;hydroxychloroquine or convalescent plasma can be considered. © 2020 Indian Medical Association. All rights reserved.